IGF1 and pancreatic neoplasm: AG1024 and I-OMe-AG538, insulin-like growth factor-1 (IGF-1) receptor tyrosine kinase inhibitors, show selective cytotoxicity in starved pancreatic tumor cells to induce necrotic death [39].